Literature DB >> 33585509

Humoral and Cellular Response of Frontline Health Care Workers Infected by SARS-CoV-2 in Nice, France: A Prospective Single-Center Cohort Study.

Marion Cremoni1,2, Caroline Ruetsch3, Kévin Zorzi2,4, Céline Fernandez2,4, Sonia Boyer-Suavet2,4, Sylvia Benzaken3, Elisa Demonchy5, Jean Dellamonica2,6, Carole Ichai7, Vincent Esnault1,2,4, Vesna Brglez2,4, Barbara Seitz-Polski1,2,3,4.   

Abstract

Frontline health care workers (HCWs) have been particularly exposed to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) since the start of the pandemic but the clinical features and immune responses of those infected with SARS-CoV-2 have not been well described. In a prospective single center cohort study, we enrolled 196 frontline HCWs exposed to the SARS-Cov-2 and 60 patients with moderate and severe forms of the coronavirus disease 2019 (COVID-19). Serological tests and cytokines assay were performed to analyze SARS-CoV-2-specific humoral and cellular immunity. Of the 196 HCWs tested, 15% had specific antibodies against SARS-CoV-2 and 45% of seropositive HCWs were strictly asymptomatic. However, in comparison to moderate and severe forms, HCWs with mild or asymptomatic forms of COVID-19 showed lower specific IgA and IgG peaks, consistent with their mild symptoms, and a robust immune cellular response, illustrated by a high production of type I and II interferons. Further studies are needed to evaluate whether this interferon functional immune assay, routinely applicable, can be useful in predicting the risk of severe forms of COVID-19.
Copyright © 2021 Cremoni, Ruetsch, Zorzi, Fernandez, Boyer-Suavet, Benzaken, Demonchy, Dellamonica, Ichai, Esnault, Brglez and Seitz-Polski.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; blood immune biomarkers; cellular response; health care workers; humoral response

Year:  2021        PMID: 33585509      PMCID: PMC7873459          DOI: 10.3389/fmed.2020.608804

Source DB:  PubMed          Journal:  Front Med (Lausanne)        ISSN: 2296-858X


  28 in total

1.  Antibody responses to SARS-CoV-2 in patients with COVID-19.

Authors:  Quan-Xin Long; Bai-Zhong Liu; Hai-Jun Deng; Gui-Cheng Wu; Kun Deng; Yao-Kai Chen; Pu Liao; Jing-Fu Qiu; Yong Lin; Xue-Fei Cai; De-Qiang Wang; Yuan Hu; Ji-Hua Ren; Ni Tang; Yin-Yin Xu; Li-Hua Yu; Zhan Mo; Fang Gong; Xiao-Li Zhang; Wen-Guang Tian; Li Hu; Xian-Xiang Zhang; Jiang-Lin Xiang; Hong-Xin Du; Hua-Wen Liu; Chun-Hui Lang; Xiao-He Luo; Shao-Bo Wu; Xiao-Ping Cui; Zheng Zhou; Man-Man Zhu; Jing Wang; Cheng-Jun Xue; Xiao-Feng Li; Li Wang; Zhi-Jie Li; Kun Wang; Chang-Chun Niu; Qing-Jun Yang; Xiao-Jun Tang; Yong Zhang; Xia-Mao Liu; Jin-Jing Li; De-Chun Zhang; Fan Zhang; Ping Liu; Jun Yuan; Qin Li; Jie-Li Hu; Juan Chen; Ai-Long Huang
Journal:  Nat Med       Date:  2020-04-29       Impact factor: 53.440

2.  Functional immune assay using interferon-gamma could predict infectious events in end-stage kidney disease.

Authors:  S Boyer-Suavet; M Cremoni; T Dupeyrat; K Zorzi; V Brglez; S Benzaken; V Esnault; B Seitz-Polski
Journal:  Clin Chim Acta       Date:  2019-11-30       Impact factor: 3.786

3.  SARS-CoV-2 specific serological pattern in healthcare workers of an Italian COVID-19 forefront hospital.

Authors:  Giovanni Sotgiu; Alessandra Barassi; Monica Miozzo; Laura Saderi; Andrea Piana; Nicola Orfeo; Claudio Colosio; Giovanni Felisati; Matteo Davì; Alberto Giovanni Gerli; Stefano Centanni
Journal:  BMC Pulm Med       Date:  2020-07-29       Impact factor: 3.317

4.  Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital.

Authors:  Alberto L Garcia-Basteiro; Gemma Moncunill; Marta Tortajada; Marta Vidal; Caterina Guinovart; Alfons Jiménez; Rebeca Santano; Sergi Sanz; Susana Méndez; Anna Llupià; Ruth Aguilar; Selena Alonso; Diana Barrios; Carlo Carolis; Pau Cisteró; Eugenia Chóliz; Angeline Cruz; Silvia Fochs; Chenjerai Jairoce; Jochen Hecht; Montserrat Lamoglia; Mikel J Martínez; Robert A Mitchell; Natalia Ortega; Nuria Pey; Laura Puyol; Marta Ribes; Neus Rosell; Patricia Sotomayor; Sara Torres; Sarah Williams; Sonia Barroso; Anna Vilella; José Muñoz; Antoni Trilla; Pilar Varela; Alfredo Mayor; Carlota Dobaño
Journal:  Nat Commun       Date:  2020-07-08       Impact factor: 14.919

5.  COVID-19 Testing, Epidemic Features, Hospital Outcomes, and Household Prevalence, New York State-March 2020.

Authors:  Eli S Rosenberg; Elizabeth M Dufort; Debra S Blog; Eric W Hall; Dina Hoefer; Bryon P Backenson; Alison T Muse; James N Kirkwood; Kirsten St George; David R Holtgrave; Brad J Hutton; Howard A Zucker
Journal:  Clin Infect Dis       Date:  2020-11-05       Impact factor: 9.079

6.  Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility.

Authors:  Melissa M Arons; Kelly M Hatfield; Sujan C Reddy; Anne Kimball; Allison James; Jesica R Jacobs; Joanne Taylor; Kevin Spicer; Ana C Bardossy; Lisa P Oakley; Sukarma Tanwar; Jonathan W Dyal; Josh Harney; Zeshan Chisty; Jeneita M Bell; Mark Methner; Prabasaj Paul; Christina M Carlson; Heather P McLaughlin; Natalie Thornburg; Suxiang Tong; Azaibi Tamin; Ying Tao; Anna Uehara; Jennifer Harcourt; Shauna Clark; Claire Brostrom-Smith; Libby C Page; Meagan Kay; James Lewis; Patty Montgomery; Nimalie D Stone; Thomas A Clark; Margaret A Honein; Jeffrey S Duchin; John A Jernigan
Journal:  N Engl J Med       Date:  2020-04-24       Impact factor: 91.245

7.  Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients.

Authors:  Jérôme Hadjadj; Nader Yatim; Darragh Duffy; Frédéric Rieux-Laucat; Solen Kernéis; Benjamin Terrier; Laura Barnabei; Aurélien Corneau; Jeremy Boussier; Nikaïa Smith; Hélène Péré; Bruno Charbit; Vincent Bondet; Camille Chenevier-Gobeaux; Paul Breillat; Nicolas Carlier; Rémy Gauzit; Caroline Morbieu; Frédéric Pène; Nathalie Marin; Nicolas Roche; Tali-Anne Szwebel; Sarah H Merkling; Jean-Marc Treluyer; David Veyer; Luc Mouthon; Catherine Blanc; Pierre-Louis Tharaux; Flore Rozenberg; Alain Fischer
Journal:  Science       Date:  2020-07-13       Impact factor: 47.728

8.  Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals.

Authors:  Ling Ni; Fang Ye; Meng-Li Cheng; Yu Feng; Yong-Qiang Deng; Hui Zhao; Peng Wei; Jiwan Ge; Mengting Gou; Xiaoli Li; Lin Sun; Tianshu Cao; Pengzhi Wang; Chao Zhou; Rongrong Zhang; Peng Liang; Han Guo; Xinquan Wang; Cheng-Feng Qin; Fang Chen; Chen Dong
Journal:  Immunity       Date:  2020-05-03       Impact factor: 31.745

9.  Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2).

Authors:  Ruiyun Li; Sen Pei; Bin Chen; Yimeng Song; Tao Zhang; Wan Yang; Jeffrey Shaman
Journal:  Science       Date:  2020-03-16       Impact factor: 47.728

10.  Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.

Authors:  Paul Bastard; Zhiyong Liu; Jérémie Le Pen; Marcela Moncada-Velez; Jie Chen; Masato Ogishi; Ira K D Sabli; Stephanie Hodeib; Cecilia Korol; Jérémie Rosain; Kaya Bilguvar; Junqiang Ye; Alexandre Bolze; Benedetta Bigio; Rui Yang; Andrés Augusto Arias; Qinhua Zhou; Yu Zhang; Richard P Lifton; Shen-Ying Zhang; Guy Gorochov; Vivien Béziat; Emmanuelle Jouanguy; Vanessa Sancho-Shimizu; Charles M Rice; Laurent Abel; Luigi D Notarangelo; Aurélie Cobat; Helen C Su; Jean-Laurent Casanova; Qian Zhang; Fanny Onodi; Sarantis Korniotis; Léa Karpf; Quentin Philippot; Marwa Chbihi; Lucie Bonnet-Madin; Karim Dorgham; Nikaïa Smith; William M Schneider; Brandon S Razooky; Hans-Heinrich Hoffmann; Eleftherios Michailidis; Leen Moens; Ji Eun Han; Lazaro Lorenzo; Lucy Bizien; Philip Meade; Anna-Lena Neehus; Aileen Camille Ugurbil; Aurélien Corneau; Gaspard Kerner; Peng Zhang; Franck Rapaport; Yoann Seeleuthner; Jeremy Manry; Cecile Masson; Yohann Schmitt; Agatha Schlüter; Tom Le Voyer; Taushif Khan; Juan Li; Jacques Fellay; Lucie Roussel; Mohammad Shahrooei; Mohammed F Alosaimi; Davood Mansouri; Haya Al-Saud; Fahd Al-Mulla; Feras Almourfi; Saleh Zaid Al-Muhsen; Fahad Alsohime; Saeed Al Turki; Rana Hasanato; Diederik van de Beek; Andrea Biondi; Laura Rachele Bettini; Mariella D'Angio'; Paolo Bonfanti; Luisa Imberti; Alessandra Sottini; Simone Paghera; Eugenia Quiros-Roldan; Camillo Rossi; Andrew J Oler; Miranda F Tompkins; Camille Alba; Isabelle Vandernoot; Jean-Christophe Goffard; Guillaume Smits; Isabelle Migeotte; Filomeen Haerynck; Pere Soler-Palacin; Andrea Martin-Nalda; Roger Colobran; Pierre-Emmanuel Morange; Sevgi Keles; Fatma Çölkesen; Tayfun Ozcelik; Kadriye Kart Yasar; Sevtap Senoglu; Şemsi Nur Karabela; Carlos Rodríguez-Gallego; Giuseppe Novelli; Sami Hraiech; Yacine Tandjaoui-Lambiotte; Xavier Duval; Cédric Laouénan; Andrew L Snow; Clifton L Dalgard; Joshua D Milner; Donald C Vinh; Trine H Mogensen; Nico Marr; András N Spaan; Bertrand Boisson; Stéphanie Boisson-Dupuis; Jacinta Bustamante; Anne Puel; Michael J Ciancanelli; Isabelle Meyts; Tom Maniatis; Vassili Soumelis; Ali Amara; Michel Nussenzweig; Adolfo García-Sastre; Florian Krammer; Aurora Pujol; Darragh Duffy
Journal:  Science       Date:  2020-09-24       Impact factor: 47.728

View more
  5 in total

1.  Mutations in spike protein T cell epitopes of SARS-COV-2 variants: Plausible influence on vaccine efficacy.

Authors:  S Sankaranarayanan; Mugdha Mohkhedkar; Vani Janakiraman
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2022-05-12       Impact factor: 6.633

2.  SARS-CoV-2 mRNA vaccine BNT162b2 triggers a consistent cross-variant humoral and cellular response.

Authors:  D Mileto; C Fenizia; M Cutrera; G Gagliardi; A Gigantiello; A De Silvestri; A Rizzo; A Mancon; M Bianchi; F De Poli; M Cuomo; I Burgo; M Longo; S G Rimoldi; C Pagani; S Grosso; V Micheli; G Rizzardini; R Grande; M Biasin; M R Gismondo; A Lombardi
Journal:  Emerg Microbes Infect       Date:  2021-12       Impact factor: 7.163

3.  Impact of Isolation Time of COVID-19 Patients in Intensive Care Unit on Healthcare Workers Contamination and Nursing Care Intensity.

Authors:  Denis Doyen; Lucas Morand; Mathieu Jozwiak; Didac Aurenche Mateu; Clément Saccheri; Hervé Hyvernat; Marion Cremoni; Vesna Brglez; Nicolas Bèle; Gilles Bernardin; Barbara Seitz-Polski; Jean Dellamonica
Journal:  Front Med (Lausanne)       Date:  2022-03-25

4.  Prognostic Value of Mid-Region Proadrenomedullin and In Vitro Interferon Gamma Production for In-Hospital Mortality in Patients with COVID-19 Pneumonia and Respiratory Failure: An Observational Prospective Study.

Authors:  Davide Mangioni; Massimo Oggioni; Liliane Chatenoud; Arianna Liparoti; Sara Uceda Renteria; Laura Alagna; Simona Biscarini; Matteo Bolis; Adriana Di Modugno; Marco Mussa; Giulia Renisi; Riccardo Ungaro; Antonio Muscatello; Andrea Gori; Ferruccio Ceriotti; Alessandra Bandera
Journal:  Viruses       Date:  2022-07-30       Impact factor: 5.818

5.  Low baseline IFN-γ response could predict hospitalization in COVID-19 patients.

Authors:  Marion Cremoni; Jonathan Allouche; Daisy Graça; Kevin Zorzi; Céline Fernandez; Maxime Teisseyre; Sylvia Benzaken; Caroline Ruetsch-Chelli; Vincent L M Esnault; Jean Dellamonica; Michel Carles; Jérôme Barrière; Michel Ticchioni; Vesna Brglez; Barbara Seitz-Polski
Journal:  Front Immunol       Date:  2022-09-26       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.